Agape ATP Corp Confirms Common Stock Listing Status

TL;DR

**ATPC's common stock is still listed, good for market access.**

AI Summary

Agape ATP Corp (ATPC) filed an 8-K on January 22, 2024, reporting that its common stock, with a par value of $0.0001 per share, is registered on an exchange, though the specific exchange is not detailed in this filing. This filing, dated January 18, 2024, indicates the company is maintaining its listing status. For investors, this matters because it confirms the company's continued compliance with listing requirements, which is crucial for liquidity and investor confidence.

Why It Matters

This filing confirms Agape ATP Corp's common stock remains listed, which is important for maintaining market access and investor trust.

Risk Assessment

Risk Level: low — The filing indicates continued listing, which generally reduces risk associated with delisting concerns.

Analyst Insight

Investors should view this filing as a routine update confirming continued listing, which is a positive for market access but doesn't provide new operational insights. Further research into the company's financials and business operations would be prudent.

Key Numbers

• $0.0001 — Par value per share (The stated par value of Agape ATP Corp's common stock.)

Key Players & Entities

• Agape ATP Corp (company) — the registrant
• $0.0001 (dollar_amount) — par value per share of common stock
• January 18, 2024 (date) — date of earliest event reported
• January 22, 2024 (date) — filing date of the 8-K
• ATPC (company) — trading symbol for Agape ATP Corp

Forward-Looking Statements

• Agape ATP Corp will maintain its current listing status on the exchange. (Agape ATP Corp) — high confidence, target: Ongoing

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share ATPC NASDAQ Capital Mark
• $1 — (2), to maintain a minimum bid price of $1 per share. Nasdaq has provided the Co

Filing Documents

• form8-k.htm (8-K) — 35KB
• 0001493152-24-003174.txt ( ) — 205KB
• atpc-20240118.xsd (EX-101.SCH) — 3KB
• atpc-20240118_lab.xml (EX-101.LAB) — 33KB
• atpc-20240118_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 3KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 18, 2024 AGAPE ATP CORPORATION (Exact name of registrant as specified in its charter) Nevada 001-41835 36-4838886 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 1705 – 1708, Level 17, Tower 2, Faber Towers , Jalan Desa Bahagia , Taman Desa , Kuala Lumpur , Malaysia 58100 (Address of principal executive offices) (Zip Code) +(60) 192230099 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share ATPC NASDAQ Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging Growth Company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 18, 2024, Agape ATP Corporation (the "Company") received a letter from the Listing Qualifications staff of The Nasdaq Stock Market ("Nasdaq") notifying the Company that based on the closing bid price of the Company for the period from November 30, 2023 to January 17, 2024, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share. Nasdaq has provided the Company with an 180 calendar days compliance period, or until July 16, 2024, in which to regain compliance with Nasdaq continued listing requirement. In the event that the Company does not regain compliance in the compliance period, the Company may be eligible for an additional 180 calendar days, should the Company meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and is able to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. However, if it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company's securities will be subject to delisting. The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq's continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AGAPE ATP CORPORATION Date: January 22, 2024 By: /s/ How Kok Choong Name: How Kok Choong Title: Chief Executive Officer, President, Director, Secretary and Treasurer (Principal Executive Officer) 3

View Full Filing

View this 8-K filing on SEC EDGAR